Live Breaking News & Updates on Cyclerion therapeutics inc

Stay updated with breaking news from Cyclerion therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

12 Best Biotech Penny Stocks to Invest In

The past few years have been a topsy-turvy ride for the biotech sector.

Indiana , United-states , Boone-county , Boston , Massachusetts , Texas , Germany , Nevada , Canada , Eli-lilly , Versanis-bio , Dave-ricks

Contrasting Cyclerion Therapeutics (NASDAQ:CYCN) & Nuvo Pharmaceuticals (OTCMKTS:MRVFF)

Contrasting Cyclerion Therapeutics (NASDAQ:CYCN) & Nuvo Pharmaceuticals (OTCMKTS:MRVFF)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , Cambridge , Cambridgeshire , United-kingdom , Massachusetts , United-states , Nuvo-pharmaceuticals-inc , Nuvo-pharmaceuticals , Service-business , Cyclerion-therapeutics-inc , Akebia-therapeutics-inc

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , United-states , Damascus , Dimashq , Syria , American , Dina-katabi , Michael-higgins , Errol-desouza , Massachusetts-institute-of-technology

Cyclerion Strengthens Board of Directors with Experienced

Cyclerion Strengthens Board of Directors with Experienced
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , United-states , Damascus , Dimashq , Syria , American , Dina-katabi , Errol-desouza , Michael-higgins , National-academy-of-engineering

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

- Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreaking wireless devices for passive assessment of symptoms, behavior, and treatment responses in...

United-states , Cambridge , Cambridgeshire , United-kingdom , Damascus , Dimashq , Syria , American , Dina-katabi , Michael-higgins , Errol-desouza , Cornell-university

Short Interest in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) Drops By 14.5%

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 15,900 shares, a decline of 14.5% from the September 15th total of 18,600 shares. Based on an average daily volume of 8,600 shares, […]

Mackenzie-financial-corp , Prelude-capital-management , Cyclerion-therapeutics-inc , Prudential-financial-inc , Nasdaq , Virtu-financial , Cyclerion-therapeutics , Get-free-report , Therapeutics-stock-down , Financial-corp , Street-group

Tisento Therapeutics Raises $81M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Cambridge , Cambridgeshire , United-kingdom , Peter-hecht , Cyclerion-therapeutics-inc , Nasdaq , Tisento-therapeutics-inc , Tisento-therapeutics , Cyclerion-therapeutics , Major-cyclerion , Sanofi-ventures ,

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) Short Interest Up 20.0% in July

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 33,600 shares, a growth of 20.0% from the June 30th total of 28,000 shares. Approximately 1.6% of the shares of the company are short sold. Based […]

Prelude-capital-management , Nasdaq , Cyclerion-therapeutics-inc , Virtu-financial , Mackenzie-financial-corp , Prudential-financial-inc , Cyclerion-therapeutics , Get-free-report , Financial-corp , Street-group , Capital-management

Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Up 0.7%

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Free Report)’s stock price rose 0.7% during trading on Tuesday . The stock traded as high as $4.17 and last traded at $4.15. Approximately 6,061 shares were traded during trading, a decline of 60% from the average daily volume of 15,031 shares. The stock had previously closed at $4.12. Cyclerion […]

Mackenzie-financial-corp , Prudential-financial-inc , Prelude-capital-management , Cyclerion-therapeutics-inc , Nasdaq , Renaissance-technologies , Cyclerion-therapeutics , Free-report , Financial-corp , Capital-management , Jane-street-group